• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹水胆固醇作为恶性腹水标志物的实用性。

Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.

作者信息

Rana Satya V, Babu Sad G Venkatesh, Kocchar Rakesh

机构信息

Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Med Sci Monit. 2005 Mar;11(3):CR136-42.

PMID:15735567
Abstract

BACKGROUND

The differential diagnosis of ascites is a common clinical problem. However, the capability to distinguish malignant from non-malignant causes of ascites using available biochemical techniques would obviate many expensive and time-consuming diagnostic studies on patients presenting with ascites of unknown etiology. Therefore, this study was planned to evaluate the diagnostic efficacy of ascitic fluid cholesterol in comparison to the efficiency of ascitic/serum total protein, pH, glucose, total leukocyte count, and the serum/ascitic albumin gradient in differentiating "malignant" from non-malignant ascites.

MATERIALS/METHODS: A total of 50 patients (25 with malignant ascites and 25 with non-malignant) were evaluated for total ascitic protein, ascites/serum (A/S) total protein ratio, serum ascites albumin gradient (SAAG), ascitic pH, serum & ascitic cholesterol with glucose.

RESULTS

The mean ascitic cholesterol level was significantly higher in malignant ascites than in non-malignant ascites, with a cut off level of 70 mg/dl for ascitic fluid cholesterol; 22/25 (88%) patients with malignant ascites could be separated from the 25 patients with non-malignant ascites. The specificity (100%) and diagnostic efficiency (94%) of ascitic fluid cholesterol is better than the 84% specificity and 86% diagnostic efficiency of serum ascitic albumin gradient.

CONCLUSIONS

Total Ascitic protein (70%), Ascitic serum protein ratio (74%), ascitic leukocyte count (54%), and malignant cytology (82%) yielded much lower diagnostic efficiency than ascitic fluid cholesterol (94%) or SAAG (86%) in the diagnosis of malignant ascites.

摘要

背景

腹水的鉴别诊断是一个常见的临床问题。然而,利用现有的生化技术区分腹水的恶性与非恶性病因的能力,将避免对病因不明的腹水患者进行许多昂贵且耗时的诊断研究。因此,本研究旨在评估腹水胆固醇的诊断效能,并与腹水/血清总蛋白、pH值、葡萄糖、白细胞总数以及血清/腹水白蛋白梯度在区分恶性腹水与非恶性腹水方面的效能进行比较。

材料/方法:共评估了50例患者(25例恶性腹水患者和25例非恶性腹水患者)的腹水总蛋白、腹水/血清(A/S)总蛋白比值、血清腹水白蛋白梯度(SAAG)、腹水pH值、血清及腹水胆固醇与葡萄糖水平。

结果

恶性腹水中的平均腹水胆固醇水平显著高于非恶性腹水,腹水胆固醇的临界值为70mg/dl;25例恶性腹水患者中的22例(88%)可与25例非恶性腹水患者区分开来。腹水胆固醇的特异性(100%)和诊断效能(94%)优于血清腹水白蛋白梯度的特异性(84%)和诊断效能(86%)。

结论

在恶性腹水的诊断中,腹水总蛋白(70%)、腹水血清蛋白比值(74%)、腹水白细胞计数(54%)和恶性细胞学检查(82%)的诊断效能远低于腹水胆固醇(94%)或SAAG(86%)。

相似文献

1
Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.腹水胆固醇作为恶性腹水标志物的实用性。
Med Sci Monit. 2005 Mar;11(3):CR136-42.
2
Ascitic fluid cholesterol in malignant and tubercular ascites.恶性和结核性腹水中的腹水胆固醇
J Assoc Physicians India. 1995 Nov;43(11):745-7.
3
Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.卡塔尔的腹水情况:腹水分析的病因及诊断价值
Singapore Med J. 2007 May;48(5):434-9.
4
Diagnosing ascitic etiology on a biochemical basis.基于生化指标诊断腹水病因。
Hepatogastroenterology. 1998 Sep-Oct;45(23):1673-7.
5
Ascitic fluid cholesterol in differential diagnosis of ascites.腹水鉴别诊断中的腹水胆固醇
J Assoc Physicians India. 1993 Oct;41(10):644-6.
6
[Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].[腹水脂质浓度及血液与腹水白蛋白浓度梯度:诊断意义]
Ann Gastroenterol Hepatol (Paris). 1989 Nov;25(6):251-6.
7
Diagnostic paracentesis. A two-step approach.诊断性腹腔穿刺术。两步法。
Ital J Gastroenterol. 1996 Feb-Mar;28(2):81-5.
8
[Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].[腹水脂质及血清-腹水白蛋白梯度在腹水鉴别诊断中的价值]
Acta Med Port. 1989 Jan-Feb;2(1):17-20.
9
Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.腹水纤维连接蛋白和胆固醇浓度在鉴别恶性肿瘤相关性腹水与非恶性腹水方面的价值。
Ann Med Interne (Paris). 1996;147(3):145-50.
10
[The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].[腹水液和血清中蛋白质浓度对腹水鉴别诊断的有效性]
Rev Gastroenterol Peru. 2002 Oct-Dec;22(4):279-86.

引用本文的文献

1
Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers.如果可以摄取,为什么要制造它:细胞外胆固醇摄取及其在乳腺癌和卵巢癌中的重要性综述。
J Exp Clin Cancer Res. 2024 Sep 6;43(1):254. doi: 10.1186/s13046-024-03172-y.
2
Evaluation of sterol‑o‑acyl transferase 1 and cholesterol ester levels in plasma, peritoneal fluid and tumor tissue of patients with endometrial cancer: A pilot study.子宫内膜癌患者血浆、腹腔液及肿瘤组织中固醇 - O - 酰基转移酶1和胆固醇酯水平的评估:一项初步研究。
Oncol Lett. 2023 Apr 18;25(6):231. doi: 10.3892/ol.2023.13817. eCollection 2023 Jun.
3
Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study.
评估 ACAT1 和 CE 水平在卵巢上皮癌患者血浆、腹腔液和肿瘤组织中的诊断和预后相关性 - 一项初步研究。
BMC Cancer. 2022 Apr 10;22(1):387. doi: 10.1186/s12885-022-09476-6.
4
Laboratory testing of extravascular body fluids: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Part I - Serous fluids.血管外体液的实验室检测:代表克罗地亚医学生物化学和实验室医学学会的国家建议。第一部分-浆膜液。
Biochem Med (Zagreb). 2020 Feb 15;30(1):010502. doi: 10.11613/BM.2020.010502. Epub 2019 Dec 15.
5
Diagnostic Utility of Serum Ascites Lipid and Protein Gradients in Differentiation of Ascites.血清腹水脂质和蛋白梯度在腹水鉴别诊断中的应用价值
Int J Hepatol. 2019 Jun 2;2019:8546010. doi: 10.1155/2019/8546010. eCollection 2019.
6
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.胆固醇激活恶性腹水癌细胞中的 LXRɑ/β 促进卵巢癌的化疗耐药性。
BMC Cancer. 2018 Dec 10;18(1):1232. doi: 10.1186/s12885-018-5152-5.
7
New Biochemical Parameters in the Differential Diagnosis of Ascitic Fluids.腹水鉴别诊断中的新生化参数
Gastroenterology Res. 2016 Feb;9(1):17-21. doi: 10.14740/gr700w. Epub 2016 Mar 8.
8
Diagnostic accuracy of ascitic cholesterol concentration for malignant ascites: a meta-analysis.腹水胆固醇浓度对恶性腹水的诊断准确性:一项荟萃分析。
Int J Clin Exp Med. 2015 Oct 15;8(10):18494-9. eCollection 2015.
9
Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites.联合检测 AFP 和 TCH 在恶性与非结核性良性腹水鉴别诊断中的价值。
Med Oncol. 2011 Dec;28 Suppl 1:S670-4. doi: 10.1007/s12032-010-9731-9. Epub 2010 Nov 2.
10
Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients.初治患者与化疗后患者腹水中血管内皮生长因子水平
Yonsei Med J. 2008 Jun 30;49(3):429-35. doi: 10.3349/ymj.2008.49.3.429.